AKESIS PHARMACEUTICALS, INC.·4

Jun 20, 5:19 PM ET

AKESIS PHARMACEUTICALS, INC. 4

4 · AKESIS PHARMACEUTICALS, INC. · Filed Jun 20, 2008

Insider Transaction Report

Form 4
Period: 2007-03-15
Lichter Jay
DirectorPresident and CEO
Transactions
  • Award

    Options to Purchase Common Stock

    2008-06-13+500,0001,500,000 total
    Exercise: $0.66Exp: 2018-06-13Common Stock (500,000 underlying)
  • Award

    Options to Purchase Common Stock

    2007-03-15+500,0001,500,000 total
    Exercise: $0.51Exp: 2017-03-15Common Stock (500,000 underlying)
Footnotes (3)
  • [F1]The options vest in monthly installments over a 31-month period commencing on the date of grant and subject to the continued status of reporting person as a service provider to the issuer on each vesting date.
  • [F2]The options vest in equal monthly installments over a three-year period commencing on the date of grant and subject to the continued status of reporting person as a service provider to the issuer on each vesting date.
  • [F3]Consists of 1,500,000 options to purchase Common Stock.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT